Back to Companies who have applied for FDA Drug Approval

FDA Drug Approval Applications Sponsored by KING PHARMS

Application NumberDrugs/ProductsApplication TypeMost Recent Label Available FlagCurrent Patent FlagAction TypeChemical TypeTher PotentialOrphan Code
007517 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
013217 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
017381 New Drug Application Approval New ester, new salt, or other noncovalent derivative (P) Priority review drug
017531 New Drug Application Approval New manufacturer (S) Standard review drug
018596 New Drug Application Approval New formulation (P) Priority review drug
018647 New Drug Application Approval New combination (S) Standard review drug
019660 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
019901 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
020545 New Drug Application Approval New formulation (S) Standard review drug
040320 Abbreviated New Drug Application Approval
050138 New Drug Application Approval
050141 New Drug Application Approval
050667 New Drug Application Approval New molecular entity (NME) (S) Standard review drug
050668 New Drug Application Approval New formulation (S) Standard review drug
050747 New Drug Application Approval New molecular entity (NME) (P) Priority review drug
050748 New Drug Application Approval New formulation (S) Standard review drug
060101 Abbreviated New Drug Application Approval
062170 Abbreviated New Drug Application Approval
062289 Abbreviated New Drug Application Approval
070106 Abbreviated New Drug Application Approval
075088 Abbreviated New Drug Application Approval
085175 Abbreviated New Drug Application Approval
086606 Abbreviated New Drug Application Approval
088508 Abbreviated New Drug Application Approval

Back to Companies who have applied for FDA Drug Approval